Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 201–300 of 2,099
Kobayashi, Y., Long, J., Dan, S., Johannsen, N. M., Talamoa, R., Raghuram, S. S., Chung, S., Kent, K., Basina, M., Lamendola, C. A., et al. (2023) · Diabetologia · doi:10.1007/s00125-023-05958-9 · Cited by 130
Goedeke, L., Perry, R. J., & Shulman, G. I. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104727 · Cited by 77
“In the muscle, insulin resistance is manifested by impaired glucose uptake following ingestion of a carbohydraterich meal and results in postprandial hyperglycemia (28), which in turn can be attributed to decreased insulin-stimulated muscle glycogen synthesis (29) due to decreased insulinstimulated glucose transport (…”
BackgroundMenshikova, E. V., Ritov, V. B., Dube, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G. S., Coen, P. M., & Goodpaster, B. H. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw328 · Cited by 80
A clinical guide to the pathophysiology, diagnosis and treatment of osteosarcopenia
Kirk, B., Miller, S., Zanker, J., & Duque, G. (2020) · Maturitas · doi:10.1016/j.maturitas.2020.05.012 · Cited by 94
Insulin-stimulated glucose uptake in healthy and insulin-resistant skeletal muscle
Deshmukh, A. S. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0041 · Cited by 92
Interaction between sarcopenia and nonalcoholic fatty liver disease
Joo, S. K., & Kim, W. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0358 · Cited by 78
“IR also inhibits growth hormone (GH)/insulin growth factor-1 (IGF-1) axis that normally plays a protective role in muscle regeneration and age-related muscle loss.(17,23,24) It causes compensatory hyperinsulinemia, which leads to promotion of gluconeogenesis, upregulation of sterol regulatory element binding protein 1…”
BackgroundBadin, P.-M., Vila, I. K., Louche, K., Mairal, A., Marques, M.-A., Bourlier, V., Tavernier, G., Langin, D., & Moro, C. (2013) · Endocrinology · doi:10.1210/en.2012-2029 · Cited by 78
“These alterations of insulin signaling are consistent with other reports and confirm that skeletal muscle is a primary site of glucose disposal and insulin action (32).”
ResultGaliero, R., Caturano, A., Vetrano, E., Cesaro, A., Rinaldi, L., Salvatore, T., Marfella, R., Sardu, C., Moscarella, E., Gragnano, F., et al. (2021) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2203082 · Cited by 98
“Skeletal muscle insulin resistance may also be implicated in steatosis development, by redistributing postprandial glucose from peripheral glycogen storage to hepatic de novo lipogenesis [55, 56].”
Molecular pharmacology and therapeutic advances of the pentacyclic triterpene lupeol
Sohag, A. A. M., Hossain, M. T., Rahaman, M. A., Rahman, P., Hasan, M. S., Das, R. C., Khan, M. K., Sikder, M. H., Alam, M., Uddin, M. J., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154012 · Cited by 90
Bedinger, D., & Adams, S. H. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.08.013 · Cited by 95
Wnt Signaling Activation in Adipose Progenitors Promotes Insulin-Independent Muscle Glucose Uptake
Zeve, D., Seo, J. H., Suh, J. M., Stenesen, D., Tang, W., Berglund, E. D., Wan, Y., Williams, L. J., Lim, A., Martinez, M. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.010 · Cited by 77
“Indeed, insulin resistance and impaired glucose uptake in muscle are hallmarks of type II diabetes (DeFronzo and Tripathy, 2009; Fujii et al., 2006; Garvey et al., 1998; Zierath et al., 1996).”
BackgroundRole of bioactive lipid mediators in obese adipose tissue inflammation and endocrine dysfunction
Lopategi, A., López‐Vicario, C., Alcaraz‐Quiles, J., García‐Alonso, V., Rius, B., Titos, E., & Clària, J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.033 · Cited by 90
“…and IKK activation in turn induces insulin resistance by disrupting tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1), a protein that connects the insulin receptor to the phosphoinositide 3-kinase (PI3K) signaling cascade (DeFronzo and Tripathy, 2009).”
InfluentialDiabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management
Singh, M. K., Das, B. K., Choudhary, S., Gupta, D., & Patil, U. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.095 · Cited by 91
Li, Y., Gao, S., Shi, S., Xiao, D., Peng, S., Gao, Y., Zhu, Y. J., & Lin, Y. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00614-6 · Cited by 91
Lactate-induced lactylation in skeletal muscle is associated with insulin resistance in humans
Maschari, D., Saxena, G., Law, T., Walsh, E., Campbell, M. C., & Consitt, L. A. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.951390 · Cited by 84
“Skeletal muscle insulin resistance is considered the primary defect leading to the development of type 2 diabetes (DeFronzo and Tripathy 2009) making skeletal muscle the ideal tissue to identify metabolic defects contributing to insulin resistance.”
BackgroundExercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle
Hingst, J. R., Bruhn, L., Hansen, M. B., Rosschou, M. F., Birk, J. B., Fentz, J., Foretz, M., Viollet, B., Sakamoto, K., Færgeman, N. J., et al. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.001 · Cited by 77
“Furthermore, impaired insulin-stimulated glycogen synthesis is a hallmark in muscle insulin resistance as observed in various diseased conditions like type 2 diabetes [61], and the present findings may indeed be applicable in therapeutic strategies.”
BackgroundInvited review: Sphingolipid biology in the dairy cow: The emerging role of ceramide
McFadden, J. W., & Rico, J. E. (2019) · Journal of Dairy Science · doi:10.3168/jds.2018-16095 · Cited by 87
Small, L., Brandon, A. E., Turner, N., & Cooney, G. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00337.2017 · Cited by 72
“Clearly, our understanding of the mechanisms involved in diet-induced, skeletal muscle insulin resistance remains incomplete despite the detailed analysis of the molecular mechanisms involved in skeletal muscle insulin action outlined in several review articles (1, 43, 69, 103, 142, 143, 177).”
BackgroundOf rodents and men: Species-specific glucose regulation and type 2 diabetes research
Chandrasekera, P. C. (2014) · ALTEX · doi:10.14573/1309231 · Cited by 89
“…in humans, accounting for 50%-90% of glucose uptake, making it the primary insulin-sensitive tissue and the primary site of dysregulation in human peripheral insulin resistance (Shulman et al., 1990; DeFronzo and Tripathy, 2009; Koistinen and Zierath, 2002; Abdul-Ghani and DeFronzo, 2010).”
InfluentialPioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease
Inzucchi, S. E., Viscoli, C. M., Young, L. H., Furie, K. L., Gorman, M., Lovejoy, A. M., Dagogo-Jack, S., Ismail-Beigi, F., Korytkowski, M. T., Pratley, R. E., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0798 · Cited by 75
Reappraisal of the optimal fasting time for insulin tolerance tests in mice
Carper, D. A., Coué, M., Laurens, C., Langin, D., & Moro, C. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101058 · Cited by 83
“Skeletal muscle is a key insulin-sensitive tissue that can contribute up to 85% of glucose disposal in response to insulin stimulation [26].”
BackgroundMaternal obesity reduces oxidative capacity in fetal skeletal muscle of Japanese macaques
McCurdy, C. E., Schenk, S., Hetrick, B., Houck, J., Drew, B. G., Kaye, S., Lashbrook, M., Bergman, B. C., Takahashi, D. L., Dean, T. A., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86612 · Cited by 75
Lipid-mediated muscle insulin resistance: different fat, different pathways?
Ritter, O., Jelenik, T., & Roden, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1310-2 · Cited by 74
“Skeletal muscle accounts for approximately 80–90 % of insulin-stimulated glucose disposal in the postprandial state [10].”
BackgroundManiar, K., Moideen, A., Mittal, A., Patil, A., Chakrabarti, A., & Banerjee, D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.12.003 · Cited by 77
“Metformin’s action on the muscle is of interest since the skeletal muscle plays a very important role in the diabetic and obese state[258].”
BackgroundArcher, E., Lavie, C. J., & Hill, J. O. (2018) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2018.06.002 · Cited by 86
Lactate production is a prioritized feature of adipocyte metabolism
Krycer, J. R., Quek, L., Francis, D., Fazakerley, D. J., Elkington, S. D., Díaz‐Vegas, A., Cooke, K. C., Weiss, F. C., Duan, X., Kurdyukov, S., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011178 · Cited by 73
“Although the adipose tissue only contributes 5% to whole-body glucose disposal following a meal in humans (5), experiments in mice have shown that expression of the insulin-responsive glucose transporter, GLUT4, in adipose tissue is essential for whole-body insulin sensitivity (6, 7).”
BackgroundFerrara, P. J., Rong, X., Maschek, J. A., Verkerke, A. R. P., Siripoksup, P., Song, H., Green, T. D., Krishnan, K. C., Johnson, J. M., TURK, J. W., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci135963 · Cited by 85
Feraco, A., Gorini, S., Armani, A., Camajani, E., Rizzo, M., & Caprio, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179327 · Cited by 84
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Bhat, N., & Mani, A. (2023) · Nutrients · doi:10.3390/nu15102323 · Cited by 92
“Normally, insulin binding and phosphorylation of insulin receptors activate a downstream cascade of reactions that culminate in the translocation of glucose transporter Glut4 to the plasma membrane, facilitating glucose uptake by the skeletal muscle [17–20].”
BackgroundTranscriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Tan, N. S., Vázquez‐Carrera, M., Montagner, A., Sng, M. K., Guillou, H., & Wahli, W. (2016) · Progress in Lipid Research · doi:10.1016/j.plipres.2016.09.001 · Cited by 84
Sharma, A., Oonthonpan, L., Sheldon, R. D., Rauckhorst, A. J., Zhu, Z., Tompkins, S. C., Cho, K., Grzesik, W. J., Gray, L. R., Scerbo, D. A., et al. (2019) · eLife · doi:10.7554/elife.45873 · Cited by 73
MicroRNA-194 Modulates Glucose Metabolism and Its Skeletal Muscle Expression Is Reduced in Diabetes
Latouche, C., Natoli, A., Reddy-Luthmoodoo, M., Heywood, S. E., Armitage, J. A., & Kingwell, B. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155108 · Cited by 77
“The development of insulin resistance is commonly seen prior to the development of T2DM [26], and has also been described in several models of maternal overnutrition [9].”
BackgroundA coding and non-coding transcriptomic perspective on the genomics of human metabolic disease
Timmons, J. A., Atherton, P. J., Larsson, O. S., Sood, S., Blokhin, I. O., Brogan, R. J., Volmar, C., Josse, A. R., Slentz, C. A., Wahlestedt, C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky570 · Cited by 80
“A feature of T2DM is a variable loss of peripheral insulin sensitivity (IS) (8,9); in humans predominantly reflecting reduced efficacy of insulin signaling (‘insulin resistance’, IR) in skeletal muscle and liver (10,11).”
BackgroundRen, L., Zhou, X., Huang, X., Wang, C., & Li, Y. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.12.015 · Cited by 77
Moreno, M., Silvestri, E., De Matteis, R., de Lange, P., Lombardi, A., Glinni, D., Senese, R., Cioffi, F., Salzano, A. M., Scaloni, A., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-181982 · Cited by 71
Focus on FKBP51: A molecular link between stress and metabolic disorders
Häusl, A. S., Balsevich, G., Gassen, N. C., & Schmidt, M. V. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.003 · Cited by 81
“importance of skeletal muscle AKT signaling in the maintenance of glucose homeostasis [92,93], we examined molecular markers and functional readouts of glucose uptake.”
BackgroundYe, C., Kong, L., Wang, Y., Zheng, J., Xu, M., Xu, Y., Li, M., Zhao, Z., Lu, J., Chen, Y., et al. (2022) · Aging Cell · doi:10.1111/acel.13923 · Cited by 79
“…which is in line with previous evidence that insulin resistance per se is a vital early manifestation of diabetes and NAFLD (Chalasani et al., 2012; DeFronzo & Tripathy, 2009), but it may be an initiator that triggers the downstream mechanisms leading to hypertension and CVDs (Laakso & Kuusisto,…”
InfluentialVascular function, insulin action, and exercise: an intricate interplay
Zheng, C., & Liu, Z. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.02.002 · Cited by 71
“Skeletal muscle is a major insulin response organ and accounts for ~ 80% of insulinstimulated whole body glucose disposal during insulin infusion [35].”
BackgroundKrüppel-Like Factors in Metabolic Homeostasis and Cardiometabolic Disease
Oishi, Y., & Manabe, I. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00069 · Cited by 89
“Our particular focus is on the physiological and pathological functions of KLFs in the liver and skeletal muscle because these organs are the major sites of regulation of systemic metabolism, and metabolic defects in these organs are essential to type 2 diabetes (14).”
BackgroundHenríquez‐Olguín, C., Boronat, S., Cabello‐Verrugio, C., Jaimovich, E., Hidalgo, E., & Jensen, T. E. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7678 · Cited by 76
“Skeletal muscle plays a quantitatively large role in whole-body glucose homeostasis and accounts for *80% of whole-body glucose disposal under hyperinsulinemic-euglycemic clamp conditions (79).”
BackgroundInfluentialTavares, G., Marques, D., Barra, C., Silva, D., Reis-Costa, A., Rodrigues, T., Gasparini, P. V. F., Melo, B. F., Sacramento, J. F., Seiça, R. M. F., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101241 · Cited by 77
“Both the BAT and skeletal muscle are considered tissues with higher metabolic rates, since the majority of disposable post-prandial glucose is taken up by the skeletal muscle [29] while BAT converts nutrients energy into chemical energy in the form of heat [30,31].”
BackgroundResultDynamic Metabolomics Reveals that Insulin Primes the Adipocyte for Glucose Metabolism
Krycer, J. R., Yugi, K., Hirayama, A., Fazakerley, D. J., Quek, L., Scalzo, R. A., Ohno, S., Hodson, M. P., Ikeda, S., Shoji, F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.085 · Cited by 80
DiMenna, F. J., & Arad, A. D. (2018) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-018-0110-8 · Cited by 68
Mid-adulthood cardiometabolic risk factor profiles of sarcopenic obesity
Ma, J., Hwang, S., McMahon, G. M., Curhan, G. C., Mclean, R. R., Murabito, J. M., & Fox, C. S. (2016) · Obesity · doi:10.1002/oby.21356 · Cited by 68
miR-378a: a new emerging microRNA in metabolism
Machado, I. F., Teodoro, J. S., Palmeira, C. M., & Rolo, A. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03375-z · Cited by 74
“It is well established that skeletal muscle has a key role in the maintenance of the organism’s glucose and energy homeostasis [34], not only because it is the most abundant tissue in the organism able to uptake most of the glucose in an insulin-dependent mechanism, but also because it is involved in a balanced crosst…”
BackgroundRegulatory Connections between Iron and Glucose Metabolism
Fillebeen, C., Lam, N. H., Chow, S., Botta, A. M., Sweeney, G., & Pantopoulos, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207773 · Cited by 78
Wang, N., Sun, Y. B., Zhang, H., Chen, C., Wang, Y., Zhang, J., Xia, F., Benedict, C., Tan, X. W., & Lu, Y. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12822 · Cited by 77
“Increased intramyocellular lipid content secondary to elevated plasma fatty free acid levels and/or excessive lipid intake will both decrease the capacity of fatty acid oxidation and develop insulin resistance.(28) More importantly, myokines secreted by muscle could crosstalk with adipokines to maintain a bal-”
BackgroundIntegrative biology of extracellular vesicles in diabetes mellitus and diabetic complications
Liu, J., Zhang, Y., Tian, Y., Huang, W. C., Tong, N., & Fu, X. (2022) · Theranostics · doi:10.7150/thno.65778 · Cited by 78
“Skeletal muscle is the major organ for glucose uptake, whose IR is one of the primary defects of T2D [398].”
BackgroundMyostatin Inhibition Prevents Diabetes and Hyperphagia in a Mouse Model of Lipodystrophy
Guo, T., Bond, N. D., Jou, W., Gavrilova, O., Portas, J., & McPherron, A. C. (2012) · Diabetes · doi:10.2337/db11-0915 · Cited by 68
“Muscle is the primary site of insulin-stimulated glucose disposal (6), and as in obesity, an increase in the concentration of lipid in skeletal muscle is known to precede diabetes in a model of lipodystrophy, the A-ZIP/F-1 mouse (hereafter called A-ZIP) (4,7).”
BackgroundWiklund, P., Zhang, X., Pekkala, S., Autio, R., Kong, L., Yang, Y., Keinanen-Kiukaanniemi, S. M., Alén, M., & Cheng, S. (2016) · Scientific Reports · doi:10.1038/srep24540 · Cited by 77
Nelson, M. E., Madsen, S., Cooke, K. C., Fritzen, A. M., Thorius, I. H., Masson, S. W. C., Carroll, L., Weiss, F. C., Seldin, M. M., Potter, M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2021.12.013 · Cited by 62
Insulin resistance of amino acid and protein metabolism in type 2 diabetes
Tessari, P., Cecchet, D., Cosma, A., Puricelli, L., Millioni, R., Vedovato, M., & Tiengo, A. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.02.009 · Cited by 79
Xirouchaki, C. E., Mangiafico, S. P., Bate, K., Ruan, Z., Huang, A. M., Tedjosiswoyo, B. W., Lamont, B., Pong, W., Favaloro, J., Blair, A. R., et al. (2016) · Molecular Metabolism · doi:10.1016/j.molmet.2016.01.004 · Cited by 67
Deshmukh, A. S., Cox, J., Jensen, L. J., Meissner, F., & Mann, M. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00720 · Cited by 67
Leem, K., Kim, M., Hahm, Y.-T., & Kim, H. K. (2016) · Nutrients · doi:10.3390/nu8120800 · Cited by 67
Monomeric cocoa catechins enhance β-cell function by increasing mitochondrial respiration
Rowley, T. J., Bitner, B. F., Ray, J. D., Lathen, D. R., Smithson, A. T., Dallon, B. W., Plowman, C. J., Bikman, B. T., Hansen, J. M., Dorenkott, M. R., et al. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.07.015 · Cited by 73
Varshney, R., Mishra, R., Das, N., Sircar, D., & Roy, P. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.05.004 · Cited by 76
Han, T. S., Al-Gindan, Y. Y., Govan, L., Hankey, C. R., & Lean, M. E. J. (2019) · Acta Diabetologica · doi:10.1007/s00592-019-01328-3 · Cited by 66
Circadian clock regulation of skeletal muscle growth and repair
Chatterjee, S., & Ma, K. (2016) · F1000Research · doi:10.12688/f1000research.9076.1 · Cited by 66
“Skeletal muscles account for approximately 85% of postprandial insulin-mediated glucose disposal, and changes in muscle function contribute to insulin resistance and metabolic syndromes 68 .”
BackgroundTriglyceride–Glucose Index as a Potential Indicator of Sarcopenic Obesity in Older People
Kim, B., Kim, G., Lee, Y., Taniguchi, K., Isobe, T., & Oh, S. (2023) · Nutrients · doi:10.3390/nu15030555 · Cited by 65
Mechanism of skeletal muscle atrophy after spinal cord injury: A narrative review
Xu, X. P., Talifu, Z., Zhang, C.-J., Gao, F., Ke, H., Pan, Y., Gong, H., Du, H., Yu, Y. H., Jing, Y.-L., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1099143 · Cited by 74
Diet‐induced obesity alters anabolic signalling in mice at the onset of skeletal muscle regeneration
Brown, L. A., Lee, D. E., Patton, J. F., Perry, R. A., Brown, J. L., Baum, J. I., Smith‐Blair, N., Greene, N. P., & Washington, T. A. (2015) · Acta Physiologica · doi:10.1111/apha.12537 · Cited by 65
“Published by John Wiley & Sons Ltd, doi: 10.1111/apha.1253746 Obesity is also associated with insulin resistance within skeletal muscle (DeFronzo & Tripathy 2009).”
BackgroundInfluentialAl‐Zoairy, R., Pedrini, M. T., Khan, M. I., Engl, J., Tschoner, A., Ebenbichler, C. F., Gstraunthaler, G. J. A., Salzmann, K., Bakry, R. S., & Niederwanger, A. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0201-1 · Cited by 73
“This study focused upon skeletal muscle cells as skeletal muscle is the predominant site of insulin-mediated glucose uptake and skeletal muscle insulin resistance is considered to be the primary defect in type 2 diabetes [27].”
BackgroundRole of Endoplasmic Reticulum-Mitochondria Communication in Type 2 Diabetes
Rieusset, J. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-4567-7_13 · Cited by 68
Microbial Regulation of Glucose Metabolism and Insulin Resistance
Crommen, S., & Simon, M.-C. (2017) · Genes · doi:10.3390/genes9010010 · Cited by 65
Insulin resistance in obesity can be reliably identified from fasting plasma insulin
ter Horst, K. W., Gilijamse, P. W., Koopman, K. E., de Weijer, B. A., Brands, M., Kootte, R. S., Romijn, J. A., Ackermans, M. T., Nieuwdorp, M., Soeters, M. R., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.125 · Cited by 69
Circadian Clocks Make Metabolism Run
Sinturel, F., Petrenko, V., & Dibner, C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.018 · Cited by 74
Type 2 diabetes: one disease, many pathways
Ha, J., & Sherman, A. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2019 · Cited by 70
Flavonoids in Decorticated Sorghum Grains Exert Antioxidant, Antidiabetic and Antiobesity Activities
Ofosu, F. K., Elahi, F., Daliri, E. B., Yeon, S., Ham, H.-J., Kim, J., Han, S., & Oh, D. (2020) · Molecules · doi:10.3390/molecules25122854 · Cited by 65
“Diabetes progression is related to excessive ROS-induced oxidative stress causing damage to cells resulting in dysregulation of several gene expression leading to impaired insulin secretion and signaling [6,8,9].”
BackgroundUHPLC-ESI-QTOF-MS/MS characterization, antioxidant and antidiabetic properties of sorghum grains
Ofosu, F. K., Elahi, F., Daliri, E. B., Tyagi, A., Chen, X. Q., Chelliah, R., Kim, J., Han, S., & Oh, D. (2020) · Food Chemistry · doi:10.1016/j.foodchem.2020.127788 · Cited by 70
Frendo‐Cumbo, S., Tokarz, V. L., Bilan, P. J., Brumell, J. H., & Klip, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.708431 · Cited by 70
Frampton, J., Murphy, K. G., Frost, G. S., & Chambers, E. S. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12820 · Cited by 72
“Indeed, skeletal muscle insulin resistance has been proposed as the principal defect in Type 2 diabetes.(9)”
BackgroundDiabetic sarcopenia: metabolic and molecular appraisal
Giha, H. A., Alamin, O. A. O., & Sater, M. S. (2022) · Acta Diabetologica · doi:10.1007/s00592-022-01883-2 · Cited by 71
“The muscle IR is believed to be the primary defect that leads to ultimate development of T2DM [5] and the T2DM is associated with up-regulation of muscle atrophy signaling, as reviewed before [6].”
BackgroundPaez, H. G., Pitzer, C. R., & Alway, S. E. (2023) · Cells · doi:10.3390/cells12020249 · Cited by 79
Hou, Y., Xiang, J., Wang, B., Duan, S., Song, R., Zhou, W., Tan, S., & He, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263650 · Cited by 82
“Insulin resistance is considered as the main pathophysiological basis of T2DM, which plays an important role in the occurrence and development of sarcopenia (76 – 78).”
BackgroundIrisin: A Multifaceted Hormone Bridging Exercise and Disease Pathophysiology
Paoletti, I., & Coccurello, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413480 · Cited by 89
“Basically, what we generally describe as “IR” is a muscle-dependent deficit, involving the decline in skeletal muscle sensitivity to insulin and insulin-dependent glucose uptake [9].”
Koster, J. D., Hostens, M., Eetvelde, M. V., Hermans, K., Moerman, S., Bogaert, H., Depreester, E., Broeck, W. V. D., & OPSOMER, G. (2015) · Journal of Dairy Science · doi:10.3168/jds.2015-9341 · Cited by 63
“Hyperinsulinemia causes downregulation of the number of insulin receptors in adipose tissue, skeletal muscle, and liver, thereby inducing a state of decreased insulin sensitivity (Crettaz and Jeanrenaud, 1980; DeFronzo and Tripathy, 2009).”
BackgroundEnwere, E. K., LaCasse, E. C., Adam, N. J., & Korneluk, R. G. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00034 · Cited by 62
“TWEAK SIGNALING IN DIABETES AND MUSCLE REGENERATION Skeletal muscle is responsible for the uptake of 80% of blood glucose (133–135); consequently, the outcome of prolonged insulin resistance in muscle is primarily type 2 diabetes (136).”
BackgroundTakiishi, T., Gysemans, C. A., Bouillon, R., & Mathieu, C. (2012) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2012.03.015 · Cited by 83
Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2
Vila‐Bedmar, R., Cruces‐Sande, M., Lucas, E., Willemen, H. L. D. M., Heijnen, C. J., Kavelaars, A., Mayor, F., & Murga, C. (2015) · Science Signaling · doi:10.1126/scisignal.aaa4374 · Cited by 62
“GRK2 depletion enhances insulin-induced phosphorylation of AKT in peripheral tissues Skeletal muscle is the major site for insulin-induced glucose disposal, and a decreased insulin response in this tissue is the initiating defect in insulinresistant states during the development of type 2 diabetes (18).”
BackgroundHan, E., Lee, Y., Kim, G., Kim, S. R., Lee, B., Kang, E. S., Ahn, C. W., & Soo, B. (2016) · Metabolism · doi:10.1016/j.metabol.2016.07.003 · Cited by 68
Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle
Jung, T. W., Chung, Y. H., Kim, H., El‐Aty, A. M. A., & Jeong, J. H. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.10.014 · Cited by 66
Type 2 Diabetes: One Disease, Many Pathways
Ha, J., & Sherman, A. (2019) · doi:10.1101/648816 · Cited by 63
The lifecycle of skeletal muscle mitochondria in obesity
Pileggi, C. A., Parmar, G., & Harper, M. (2021) · Obesity Reviews · doi:10.1111/obr.13164 · Cited by 61
AKT ISOFORMS-AS160-GLUT4: The defining axis of insulin resistance
Sharma, M., & Dey, C. S. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09652-2 · Cited by 256
Extracellular miRNAs as mediators of obesity‐associated disease
Brandão, B. B., Lino, M., & Kahn, C. R. (2021) · The Journal of Physiology · doi:10.1113/jp280910 · Cited by 64
“Skeletal muscle is a major site for glucose disposal and glycogen storage (DeFronzo & Tripathy, 2009).”
BackgroundScheel, A. K., Espelage, L., & Chadt, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094759 · Cited by 71
“The skeletal muscle represents the primary regulator of post-prandial glucose clearance by accounting for over 80% of glucose disposal [32].”
BackgroundLee, D. E., Brown, J. L., Rosa, M. E., Brown, L. A., Perry, R. A., Wiggs, M. P., Nilsson, M. I., Crouse, S. F., Fluckey, J. D., Washington, T. A., et al. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25476 · Cited by 71
“Importantly, Type 2 Diabetes Mellitus (T2DM) appears to begin with the development of insulin resistance in skeletal muscle [DeFronzo and Tripathy, 2009].”
BackgroundNagashima, T., Shirakawa, H., Nakagawa, T., & Kaneko, S. (2016) · Scientific Reports · doi:10.1038/srep26375 · Cited by 71
TBC1D4 Is Necessary for Enhancing Muscle Insulin Sensitivity in Response to AICAR and Contraction
Kjøbsted, R., Chadt, A., Jørgensen, N. O., Kido, K., Larsen, J. K., de Wendt, C., Al-Hasani, H., & Wojtaszewski, J. F. P. (2019) · Diabetes · doi:10.2337/db18-0769 · Cited by 62
“Impaired insulin-stimulated glucose uptake in skeletal muscle is a key defect in the pathogenesis of type 2 diabetes (1).”
BackgroundLake, J. A., & Abasht, B. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00169 · Cited by 67
Skeletal muscle and MASLD: Mechanistic and clinical insights
Marjot, T., Armstrong, M. J., & Stine, J. G. (2025) · Hepatology Communications · doi:10.1097/hc9.0000000000000711 · Cited by 84
“[11] Clamp studies have shown that patients with MASLD have a reduction in rates of glucose disposal compared with healthy volunteers.”
Tunduguru, R., Chiu, T. T., Ramalingam, L., Elmendorf, J. S., Klip, A., & Thurmond, D. C. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.033 · Cited by 61
“Defects and/or deficiencies in insulin-stimulated glucose uptake by these peripheral tissues promote the development of peripheral insulin resistance and pre-diabetes [4,5].”
Hernández‐Álvarez, M. I., Díaz‐Ramos, A., Berdasco, M., Cobb, J. E., Planet, E., Cooper, D., Pazderska, A., Wanic, K., O’Hanlon, D., Gómez, A., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14120-6 · Cited by 61
de Ligt, M., Bergman, M., Mancilla, R., Essers, J. M. N. H., Moonen‐Kornips, E., Havekes, B., Schrauwen‐Hinderling, V. B., & Schrauwen, P. (2020) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa125 · Cited by 64
“Main exclusion criteria were uncontrolled hypertension, glycated hemoglobin (HbA1c) >48 mmol/mol, diagnosed with T2D, alcohol consumption >20 g/d, use of medication known to interfere with glucose homeostasis/metabolism, and participation in another biomedical study within 1 mo prior to start of the intervention.”
BackgroundInfluentialEsteves, J. V. D. C., Yonamine, C. Y., Júnior, D. A. C. P., Gerlinger‐Romero, F., Enguita, F. J., & Machado, U. F. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00536 · Cited by 65
“Keywords: microRNA, skeletal muscle, GLUT4, hexokinase, glucose metabolism, glucose uptake, NFKB, streptozotocin INTRODUCTION Diabetes mellitus (DM) is a complex metabolic disease characterized by hyperglycemia resulting from defects in insulin secretion and/or action; and type 1 diabetes mellitus (T1DM) and type 2 di…”
InfluentialLiu, D., Xiao, Y., Zhou, B., Gao, S., Li, L., Zhao, L., Chen, W., Dai, B., Li, Q., Duan, H., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa473 · Cited by 63
Potential of Creatine in Glucose Management and Diabetes
Solis, M. Y., Artioli, G. G., & Gualano, B. (2021) · Nutrients · doi:10.3390/nu13020570 · Cited by 59
Changes in Cells Associated with Insulin Resistance
Szablewski, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042397 · Cited by 88
“Therefore, muscular insulin resistance is the primary defect in T2DM and may affect whole-body metabolism [118–120].”
BackgroundLiang, H., Tantiwong, P., Sriwijitkamol, A., Shanmugasundaram, K., Mohan, S., Espinoza, S., DeFronzo, R. A., Dubé, J. J., & Musi, N. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2012.247510 · Cited by 59
“Skeletal muscle insulin resistance is one of the earliest abnormalities in the natural history of type 2 diabetes mellitus (T2DM) (Lillioja et al. 1988; Warram et al. 1990; DeFronzo & Tripathy, 2009).”
BackgroundSelf-citation
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.